CN102627610A - 一类苯并咪唑类衍生物及其应用 - Google Patents
一类苯并咪唑类衍生物及其应用 Download PDFInfo
- Publication number
- CN102627610A CN102627610A CN2012101060994A CN201210106099A CN102627610A CN 102627610 A CN102627610 A CN 102627610A CN 2012101060994 A CN2012101060994 A CN 2012101060994A CN 201210106099 A CN201210106099 A CN 201210106099A CN 102627610 A CN102627610 A CN 102627610A
- Authority
- CN
- China
- Prior art keywords
- alkyl
- aryl
- alkoxyl group
- monocyclic cycloalkyl
- carbon monocyclic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC(*C*)C(C(C)C(C1)C2C1=CCC2)=C Chemical compound CC(*C*)C(C(C)C(C1)C2C1=CCC2)=C 0.000 description 3
- NAWJZCSEYBQUGY-UHFFFAOYSA-N NC(c(cccc1N)c1N)=O Chemical compound NC(c(cccc1N)c1N)=O NAWJZCSEYBQUGY-UHFFFAOYSA-N 0.000 description 2
- BKHQMQYSHSRYBR-UHFFFAOYSA-N NC(c1c2nc(-c(cc3)ccc3C(N3CCCC3)=O)[nH]c2ccc1)=O Chemical compound NC(c1c2nc(-c(cc3)ccc3C(N3CCCC3)=O)[nH]c2ccc1)=O BKHQMQYSHSRYBR-UHFFFAOYSA-N 0.000 description 1
- XTXKPVXZEDERLE-UHFFFAOYSA-N O=Cc(cc1)ccc1C(N1CCCC1)=O Chemical compound O=Cc(cc1)ccc1C(N1CCCC1)=O XTXKPVXZEDERLE-UHFFFAOYSA-N 0.000 description 1
- GDKMGFZUGQYCEO-UHFFFAOYSA-N O=Cc(cc1)ccc1C(NCc1ccc[o]1)=O Chemical compound O=Cc(cc1)ccc1C(NCc1ccc[o]1)=O GDKMGFZUGQYCEO-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210106099.4A CN102627610B (zh) | 2012-04-11 | 2012-04-11 | 一类苯并咪唑类衍生物及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210106099.4A CN102627610B (zh) | 2012-04-11 | 2012-04-11 | 一类苯并咪唑类衍生物及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102627610A true CN102627610A (zh) | 2012-08-08 |
CN102627610B CN102627610B (zh) | 2014-06-25 |
Family
ID=46586033
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210106099.4A Active CN102627610B (zh) | 2012-04-11 | 2012-04-11 | 一类苯并咪唑类衍生物及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102627610B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014164749A1 (en) | 2013-03-13 | 2014-10-09 | Forma Therapeutics, Inc. | Novel compounds and compositions for inhibition of fasn |
JP2016515550A (ja) * | 2013-03-21 | 2016-05-30 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung | Fasn阻害剤としてのピペラジン誘導体 |
US10793554B2 (en) | 2018-10-29 | 2020-10-06 | Forma Therapeutics, Inc. | Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone |
US10875848B2 (en) | 2018-10-10 | 2020-12-29 | Forma Therapeutics, Inc. | Inhibiting fatty acid synthase (FASN) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1195985A (zh) * | 1995-08-02 | 1998-10-14 | 钮卡斯尔大学风险投资有限公司 | 苯并咪唑化合物 |
CN101511821A (zh) * | 2006-05-02 | 2009-08-19 | 艾博特公司 | 取代的1h-苯并咪唑-4-羧酰胺类化合物是有效的parp抑制剂 |
-
2012
- 2012-04-11 CN CN201210106099.4A patent/CN102627610B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1195985A (zh) * | 1995-08-02 | 1998-10-14 | 钮卡斯尔大学风险投资有限公司 | 苯并咪唑化合物 |
CN101511821A (zh) * | 2006-05-02 | 2009-08-19 | 艾博特公司 | 取代的1h-苯并咪唑-4-羧酰胺类化合物是有效的parp抑制剂 |
Non-Patent Citations (1)
Title |
---|
ALEX W.WHITE ET AL: "Resistance-Modifying Agents. 9.1 Synthesis and Biological Properties of Benzimidazole Inhibitors of the DNA Repair Enzyme Poly(ADP-ribose) Polymerase", 《J. MED. CHEM.》 * |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019048833A (ja) * | 2013-03-13 | 2019-03-28 | フォーマ セラピューティクス,インコーポレイテッド | Fasnを阻害するための新規化合物および組成物 |
RU2737434C2 (ru) * | 2013-03-13 | 2020-11-30 | Форма Терапьютикс, Инк. | Новые соединения и композиции для ингибирования fasn |
US10995078B2 (en) | 2013-03-13 | 2021-05-04 | Forma Therapeutics, Inc. | Compounds and compositions for inhibition of FASN |
JP2016517412A (ja) * | 2013-03-13 | 2016-06-16 | フォーマ セラピューティクス,インコーポレイテッド | Fasnを阻害するための新規化合物および組成物 |
EP2968316A4 (en) * | 2013-03-13 | 2016-09-21 | Forma Therapeutics Inc | NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITING FASN |
WO2014164749A1 (en) | 2013-03-13 | 2014-10-09 | Forma Therapeutics, Inc. | Novel compounds and compositions for inhibition of fasn |
CN105492008A (zh) * | 2013-03-13 | 2016-04-13 | 福马治疗股份有限公司 | 用于抑制fasn的新型化合物及组合物 |
RU2686323C2 (ru) * | 2013-03-13 | 2019-04-25 | Форма Терапьютикс, Инк. | Новые соединения и композиции для ингибирования fasn |
US10457655B2 (en) | 2013-03-13 | 2019-10-29 | Forma Therapeutics, Inc. | Compounds and compositions for inhibition of FASN |
US10450286B2 (en) | 2013-03-13 | 2019-10-22 | Forma Therapeutics, Inc. | Compounds and compositions for inhibition of FASN |
US10399951B2 (en) | 2013-03-13 | 2019-09-03 | Forma Therapeutics, Inc. | Compounds and compositions for inhibition of FASN |
US10472342B2 (en) | 2013-03-13 | 2019-11-12 | Forma Therapeutics, Inc. | Compounds and compositions for inhibition of FASN |
CN112521369A (zh) * | 2013-03-13 | 2021-03-19 | 福马治疗股份有限公司 | 用于抑制fasn的化合物及组合物 |
US10800750B2 (en) | 2013-03-13 | 2020-10-13 | Forma Therapeutics, Inc. | Compounds and compositions for inhibition of FASN |
EP2976328B1 (en) | 2013-03-21 | 2017-05-03 | Merck Patent GmbH | Piperazine derivatives as fasn inhibitors |
JP2016515550A (ja) * | 2013-03-21 | 2016-05-30 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung | Fasn阻害剤としてのピペラジン誘導体 |
US10875848B2 (en) | 2018-10-10 | 2020-12-29 | Forma Therapeutics, Inc. | Inhibiting fatty acid synthase (FASN) |
US11299484B2 (en) | 2018-10-10 | 2022-04-12 | Forma Therapeutics, Inc. | Inhibiting fatty acid synthase (FASN) |
US10793554B2 (en) | 2018-10-29 | 2020-10-06 | Forma Therapeutics, Inc. | Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone |
US11267805B2 (en) | 2018-10-29 | 2022-03-08 | Forma Therapeutics, Inc. | Solid forms of (4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl) piperazine-1-yl)(1-hydroxycyclopropyl)methanone |
Also Published As
Publication number | Publication date |
---|---|
CN102627610B (zh) | 2014-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106102737B (zh) | 色甘酸衍生物以及成像和治疗的相关方法 | |
CA2723233A1 (en) | Specific inhibitors for vascular endothelial growth factor receptors | |
CN105523955B (zh) | 化合物及其在制备药物中的用途 | |
CN104302635A (zh) | 5-[[4-[[吗啉-2-基]甲基氨基]-5-(三氟甲基)-2-吡啶基]氨基]吡嗪-2-腈及其治疗应用 | |
CA2533747C (en) | Heterocyclic compounds useful as malonyl-coa decarboxylase inhibitors | |
EA011074B1 (ru) | Гидразидсодержащие соединения - ингибиторы cftr и их применение | |
CN102627610B (zh) | 一类苯并咪唑类衍生物及其应用 | |
KR20240021884A (ko) | 암을 치료하기 위한 parp 억제제와 조합된 atr 억제제의 용도 | |
JP6407444B2 (ja) | トリフルオロアセトヒドラジド類化合物及びその調製方法並びに製薬における応用 | |
CN104140426A (zh) | 嘧啶并咪唑类化合物、其药物组合物及其制备方法和用途 | |
TWI391132B (zh) | 憂鬱症或焦慮症用預防或治療劑 | |
Siddiqui et al. | Antidepressant, analgesic activity and SAR studies of substituted benzimidazoles | |
CN103524372B (zh) | 一种组蛋白去乙酰化酶抑制剂 | |
WO2021238588A1 (zh) | 一种噁噻嗪类化合物及其用途 | |
CN109824637A (zh) | 一种茚酮查尔酮氨基甲酸酯类化合物及其制备方法和用途 | |
CN106146504B (zh) | 一种杂环并咪唑类化合物、其药物组合物及其制备方法和用途 | |
CN101230045A (zh) | 芳环并三嗪类衍生物及其应用 | |
EP3012248B1 (en) | Substance having tyrosine kinase inhibitory activity and preparation method and use thereof | |
CN103923088B (zh) | 2,5-二氮杂双环[2.2.1]庚烷类化合物和制备方法、其药用组合物及其在医药上的应用 | |
CN102731416A (zh) | 1-(芳基甲基)-喹唑啉-2,4-二酮作为parp抑制剂及其应用 | |
CN102617478B (zh) | 苯并咪唑、噁唑和噻唑衍生物的合成及其应用 | |
EP4119165A1 (en) | Novel 3,5-diaminobenzoic acid compound, and pin1 inhibitor and therapeutic agent for inflammatory diseases using same | |
TW201602086A (zh) | 作為抗癌藥物之芳基胺取代的喹喔啉 | |
CN102875479B (zh) | 喹唑啉二酮衍生物及其制备方法、其药物组合物及用途 | |
Zhang et al. | Rational design and optimization of novel 4-methyl quinazoline derivatives as PI3K/HDAC dual inhibitors with benzamide as zinc binding moiety for the treatment of acute myeloid leukemia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: NANJING SIMCERE DONGYUAN PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: JIANGSU SIMCERE PHARMACEUTICAL RESEARCH COMPANY LIMITED Effective date: 20150331 Owner name: JIANGSU SIMCERE PHARMACEUTICAL CO., LTD. Effective date: 20150331 |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 210042 NANJING, JIANGSU PROVINCE TO: 211800 NANJING, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150331 Address after: 211800, No. 8, prosperous road, Pukou Economic Development Zone, Jiangsu, Nanjing Patentee after: Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd. Patentee after: Jiangsu Simcere Pharmaceutical Co., Ltd. Address before: 210042 Xuanwu District, Xuanwu District, Jiangsu, Nanjing No. 699 -18 Patentee before: Jiangsu Simcere Pharmaceutical Research Company Limited |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: No.99, Huakang Road, Jiangbei new district, Nanjing, Jiangsu Province, 210032 Patentee after: SIMCERE PHARMACEUTICAL Group Patentee after: JIANGSU SIMCERE PHARMACEUTICAL Co.,Ltd. Address before: 211800, No. 8, prosperous road, Pukou Economic Development Zone, Jiangsu, Nanjing Patentee before: NANJING SIMCERE DONGYUAN PHARMACEUTICA Co.,Ltd. Patentee before: JIANGSU SIMCERE PHARMACEUTICAL Co.,Ltd. |